Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06706908 · ClinicalTrials.gov registry record
Innovative Spinopelvic Solutions With Real-World Evidence
A clinical trial, sponsored by SI-BONE.
- Active
- Registry status
- 1,000
- Enrollment target
NCT06706908: Active study, sponsored by SI-BONE.
NCT06706908 is a clinical trial that is active but no longer recruiting, run by SI-BONE. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06706908 is active but no longer recruiting, sponsored by SI-BONE.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
INSPIRE is a prospective decentralized study evaluating post-operative health outcomes in patients who undergo a procedure using implants manufactured by SI-BONE.
Primary Outcome
Change in pain as rated on a numerical rating scale (NRS), 0 being no pain and 10 being the worst pain imaginable at baseline and follow-up timepoints.
Interventions
- OTHER Health questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-12-15 |
| Est. Completion | 2034-12 |
What the registry record for NCT06706908 still lists
NCT06706908 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Health questionnaires is the first listed.
NCT06706908 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06706908 about?
NCT06706908 is a clinical study titled "Innovative Spinopelvic Solutions With Real-World Evidence". INSPIRE is a prospective decentralized study evaluating post-operative health outcomes in patients who undergo a procedure using implants manufactured by SI-BONE.
What is the current status of trial NCT06706908?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2024-12-15. Estimated completion is 2034-12.
What interventions are being tested in trial NCT06706908?
The interventions under investigation include: Health questionnaires (OTHER).
Who is sponsoring clinical trial NCT06706908?
This trial is sponsored by SI-BONE, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI